Announcements Trials

Browse Landscape

Phase

Phase NA 13 Phase 1 12 Phase 1/2 7 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 37 Carcinoma, Non-Small-Cell Lung 30 Prostatic Neoplasms 20 Neoplasm Metastasis 19 Breast Neoplasms 19 Colorectal Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 14 Leukemia, Myeloid, Acute 13 Stomach Neoplasms 12 Ovarian Neoplasms 12 Melanoma 12 Lung Neoplasms 12 Carcinoma, Hepatocellular 12 Recurrence 11 Hematologic Neoplasms 10 Endometrial Neoplasms 10 Rectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Pancreatic Neoplasms 9 Lymphoma 9 Head and Neck Neoplasms 9 Myasthenia Gravis 8 Leukemia 8 Fatigue 8 Urinary Bladder Neoplasms 7 Neoplasms by Site 7 Neoplasms by Histologic Type 7 Lymphoma, Large B-Cell, Diffuse 7 Glioblastoma 7 Colonic Neoplasms 6

Interventions

Psychotherapy 1 Niacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Advanced Cancer × 1 year × Clear all

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡